These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2874986)

  • 21. Etifoxine: evaluation of its anticonvulsant profile in mice in comparison with sodium valproate, phenytoin and clobazam.
    Kruse HJ; Kuch H
    Arzneimittelforschung; 1985; 35(1):133-5. PubMed ID: 2859023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance to the anticonvulsant effects of clobazam in mice.
    Wildin JD; Pleuvry BJ
    Neuropharmacology; 1992 Feb; 31(2):129-35. PubMed ID: 1553026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam.
    Sankar R
    CNS Drugs; 2012 Mar; 26(3):229-44. PubMed ID: 22145708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clobazam in catamenial epilepsy. A model for evaluating anticonvulsants.
    Feely M; Calvert R; Gibson J
    Lancet; 1982 Jul; 2(8289):71-3. PubMed ID: 6123810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
    Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with clobazam: a new 1,5 benzodiazepine in the treatment of refractory epilepsy.
    Vajda FJ; Bladin PF; Parsons BJ
    Clin Exp Neurol; 1985; 21():177-82. PubMed ID: 3843217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species differences in clobazam metabolism and antileptazol effect.
    Caccia S; Guiso G; Samanin R; Garattini S
    J Pharm Pharmacol; 1980 Feb; 32(2):101-3. PubMed ID: 6103027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in the development of tolerance to two anticonvulsant benzodiazepines in the amygdaloid kindled rat.
    Young NA; Lewis SJ; Harris QL; Jarrott B; Vajda FJ
    J Pharm Pharmacol; 1988 May; 40(5):365-7. PubMed ID: 2899635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma concentrations of clobazam and its N-desmethyl metabolite; protection against pentetrazol-induced convulsions in mice.
    Haigh JR; Gent JP; Calvert R
    J Pharm Pharmacol; 1984 Sep; 36(9):636-8. PubMed ID: 6149294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.
    McKernan RM; Rosahl TW; Reynolds DS; Sur C; Wafford KA; Atack JR; Farrar S; Myers J; Cook G; Ferris P; Garrett L; Bristow L; Marshall G; Macaulay A; Brown N; Howell O; Moore KW; Carling RW; Street LJ; Castro JL; Ragan CI; Dawson GR; Whiting PJ
    Nat Neurosci; 2000 Jun; 3(6):587-92. PubMed ID: 10816315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacological profile of chlordesmethyldiazepam and other benzodiazepines.
    Chojnacka-Wójcik E; Tatarczyńska E; Wiczyńska B; Lewandowska A; Przegaliński E
    Pol J Pharmacol Pharm; 1986; 38(2):207-13. PubMed ID: 2875452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long-term effect of clobazam as adjunctive therapy in epilepsy.
    Scott DF; Moffett A
    Acta Neurol Scand; 1988 Jun; 77(6):498-502. PubMed ID: 3407388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disappointing results of increasing benzodiazepine dose after the development of anticonvulsant tolerance.
    Haigh JR; Gent JP; Garratt JC; Pullar T; Feely M
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):1008-9. PubMed ID: 3204393
    [No Abstract]   [Full Text] [Related]  

  • 34. Clobazam: A Safe, Efficacious, and Newly Rediscovered Therapeutic for Epilepsy.
    Gauthier AC; Mattson RH
    CNS Neurosci Ther; 2015 Jul; 21(7):543-8. PubMed ID: 25917225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Synthesis and pharmacologic study of 1,5-benzodiazepine-2,4-diones and their alkyl derivatives].
    Zellou A; Cherrah Y; Hassar M; Essassi EM
    Ann Pharm Fr; 1998; 56(4):169-74. PubMed ID: 9770010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of tolerance to anticonvulsant effect of clobazam.
    Allen JW; Jawad S; Oxley J; Trimble M
    J Neurol Neurosurg Psychiatry; 1985 Mar; 48(3):284-5. PubMed ID: 3981203
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of clobazam and its active metabolite on GABA-activated currents in rat cerebral neurons in culture.
    Nakamura F; Suzuki S; Nishimura S; Yagi K; Seino M
    Epilepsia; 1996 Aug; 37(8):728-35. PubMed ID: 8764810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability.
    Hindmarch I; Gudgeon AC
    Br J Clin Pharmacol; 1980 Aug; 10(2):145-50. PubMed ID: 6107116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Synthesis and pharmacologic study of 1,5-dialkyl-1,5-benzodiazepine-2,4-dithiones].
    Zellou A; Keita A; Cherrah Y; Essassi EM; Hassar M
    Therapie; 1999; 54(5):645-9. PubMed ID: 10667103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clobazam for treatment of intractable epilepsy: a critical assessment.
    Schmidt D
    Epilepsia; 1994; 35 Suppl 5():S92-5. PubMed ID: 8039480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.